Real world impact and experience of Abbott Freestyle Libre Glucose Monitoring

Charlotte Gordon*

*Corresponding author for this work

Research output: Contribution to conferencePoster

Abstract

Abbott Freestyle Libre (FSL) is a form of ‘wearable’ glucose sensor which enables the monitoring of blood glucose levels without finger-prick testing; FSL has been shown to safely and significantly reduce HbA1c levels in people living with type 1 diabetes who have high levels of HbA1c (Lelarathna et al, 2022).
The aim of this study is to To investigate the real-world impact of Abbott Freestyle Libre glucose monitoring (FSL) on physiological, psychological and social measures and how this relates to the lived experience of people living with type 1 diabetes (T1D) using these devices, using a mixed methods approach.
Original languageEnglish
Number of pages1
Publication statusAccepted/In press - 8 Aug 2022
EventPSAD - RAPID conference: Research Accelerating Psychosocial Innovations in Diabetes - Copenhagen, Denmark
Duration: 29 Nov 20221 Dec 2022
https://www.psadgroup.org/annual-meeting/

Conference

ConferencePSAD - RAPID conference
Abbreviated titleRAPID
Country/TerritoryDenmark
CityCopenhagen
Period29/11/221/12/22
Internet address

Fingerprint

Dive into the research topics of 'Real world impact and experience of Abbott Freestyle Libre Glucose Monitoring'. Together they form a unique fingerprint.

Cite this